PHK
REGN icon

Point72 Hong Kong’s Regeneron Pharmaceuticals REGN Stock Holding History

Point72 Hong Kong’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.72M Buy
+11,958
New +$6.76M 0.31% 63
2024
Q1 		– Sell
-8,184
Closed -$7.19M – 754
2023
Q4 		$7.19M Buy
+8,184
New +$6.74M 0.43% 66
2022
Q4 		– Sell
-50
Closed -$34K – 1340
2022
Q3 		$34K Buy
+50
New +$31.5K ﹤0.01% 1527
2022
Q2 		– Sell
-4,065
Closed -$2.64M – 2326
2022
Q1 		$2.84M Buy
4,065
+3,294
+427% +$2.08M 0.1% 244
2021
Q4 		$487K Sell
771
-2,702
-78% -$1.66M 0.02% 777
2021
Q3 		$2.1M Buy
3,473
+3,192
+1,136% +$1.98M 0.07% 444
2021
Q2 		$157K Buy
+281
New +$142K 0.01% 1214
2021
Q1 		– Sell
-1,296
Closed -$631K – 2137
2020
Q4 		$626K Buy
+1,296
New +$700K 0.03% 642
2020
Q2 		– Sell
-348
Closed -$170K – 1380
2020
Q1 		$170K Sell
348
-137
-28% -$56.5K 0.08% 112
2019
Q4 		$182K Buy
+485
New +$163K 0.04% 353
2019
Q2 		– Sell
-136
Closed -$56K – 1357
2019
Q1 		$56K Buy
136
+99
+268% +$40.8K 0.02% 513
2018
Q4 		$14K Buy
+37
New +$13.5K 0.01% 498
2018
Q1 		– Sell
-42
Closed -$16K – 1104
2017
Q4 		$16K Buy
+42
New +$17K 0.01% 413
2016
Q3 		– Sell
-2,120
Closed -$740K – 846
2016
Q2 		$740K Buy
+2,120
New +$816K 0.86% 34
2016
Q1 		– Sell
-20
Closed -$11K – 613
2015
Q4 		$11K Buy
+20
New +$10.8K 0.04% 262
2015
Q1 		– Sell
-1,420
Closed -$583K – 443
2014
Q4 		$583K Buy
+1,420
New +$558K 0.58% 19

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Hong Kong's REGN Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2025: 11,958 shares worth $6.72M. The stake represents 0.31% of the portfolio and ranks #63 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in REGN as recently as Q4 2023.

Point72 Hong Kong first reported a position in REGN in Q4 2014 and has held it in 16 quarters since. The position peaked at $7.19M in Q4 2023. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Point72 Hong Kong held 11,958 shares of Regeneron Pharmaceuticals worth $6.72M as of Q3 2025.
  • Regeneron Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
  • Regeneron Pharmaceuticals made up 0.31% of Point72 Hong Kong's portfolio in Q3 2025, its #63 holding.
  • Point72 Hong Kong first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 16 quarters since.
  • Point72 Hong Kong's Regeneron Pharmaceuticals position peaked at $7.19M in Q4 2023.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.